Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Varenicline in Hypocholinergic Parkinson Disease
NCT06679374Phase 2Recruiting
- Start
- Apr 2025
- Primary completion
- Jan 2029
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of varenicline in Parkinson's disease (PD). Started Apr 2025; status: recruiting.
02
Drugs
varenicline
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT06679374.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06679374.